Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gene Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06445322
What this trial is testing

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

Who this might be right for
Stargardt DiseaseStargardt Disease 1Cone Rod Dystrophy+1 more
Ascidian Therapeutics, Inc 50
Not applicableLooking for participantsNCT05166694
What this trial is testing

Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

Who this might be right for
CancerAdvanced CancerAdvanced Solid Tumor+2 more
University of Chicago 1,300
Not applicableStudy completedNCT02943330
What this trial is testing

Depression, Genes, Cytokines, Chronic Fatigue, Physical Illnesses and Quality of Life

Who this might be right for
HemodialysisHepatitis C
Chang Gung Memorial Hospital 170
Early research (Phase 1)Looking for participantsNCT06186401
What this trial is testing

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

Who this might be right for
EGFR Gene MutationGlioblastomaMGMT-Unmethylated Glioblastoma+1 more
Hideho Okada, MD, PhD 20
Not applicableLooking for participantsNCT02670408
What this trial is testing

Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

Who this might be right for
Cardiac Transplant Disorder
University of Alberta 900
Testing effectiveness (Phase 2)UnknownNCT06492850
What this trial is testing

Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa

Who this might be right for
X-Linked Retinitis Pigmentosa (XLRP)
Frontera Therapeutics 32
Large-scale testing (Phase 3)Study completedNCT03293524
What this trial is testing

Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year

Who this might be right for
Leber Hereditary Optic Neuropathy
GenSight Biologics 98
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06275620
What this trial is testing

A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)

Who this might be right for
X-Linked Retinitis Pigmentosa
Beacon Therapeutics 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07681778
What this trial is testing

Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD)

Who this might be right for
Leber Congenital AmaurosisLeber Congenital Amaurosis (LCA)
Opus Genetics, Inc 10
Early research (Phase 1)Study completedNCT00078520
What this trial is testing

Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells

Who this might be right for
LeukemiaLeukemia, B-Cell, Chronic
Baylor College of Medicine 9
Testing effectiveness (Phase 2)Study completedNCT02016755
What this trial is testing

A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia

Who this might be right for
Critical Limb IschemiaVascular DiseasesPeripheral Arterial Disease
AnGes USA, Inc. 10
Not applicableEnrolling By InvitationNCT07310485
What this trial is testing

Examining the Impact of Phytoestrogens Supplementation on the Gene Expression, and Premenstrual Syndrome in Primenopausal Women

Who this might be right for
Apparently Healthy and Not Receiving Hormonal Therapy
University of Jordan 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04716946
What this trial is testing

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

Who this might be right for
NSCLCNon-small Cell Lung CancerLung Cancer+5 more
Memorial Sloan Kettering Cancer Center 13
Not applicableLooking for participantsNCT06311708
What this trial is testing

Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Who this might be right for
Arrhythmogenic Right Ventricular Cardiomyopathy
Tenaya Therapeutics 200
Not applicableStudy completedNCT00002924
What this trial is testing

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 184
Large-scale testing (Phase 3)Looking for participantsNCT05568719
What this trial is testing

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

Who this might be right for
Hemophilia AHemophilia B
Pfizer 173
Testing effectiveness (Phase 2)Study completedNCT01019434
What this trial is testing

Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 111
Large-scale testing (Phase 3)Study completedNCT02427464
What this trial is testing

Phase 3 Gene Therapy for Painful Diabetic Neuropathy

Who this might be right for
Painful Diabetic NeuropathyDiabetic Neuropathy, Painful
Helixmith Co., Ltd. 507
Testing effectiveness (Phase 2)UnknownNCT04069533
What this trial is testing

Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A

Who this might be right for
Fanconi Anemia Complementation Group A
Rocket Pharmaceuticals Inc. 7
Early research (Phase 1)Study completedNCT02215967
What this trial is testing

Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma

Who this might be right for
Myeloma, Plasma-CellMyeloma-Multiple
National Cancer Institute (NCI) 30
Next Page